Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$253.3 - $285.89 $196,814 - $222,136
-777 Reduced 15.5%
4,235 $1.09 Million
Q1 2023

May 04, 2023

SELL
$256.56 - $292.34 $92,361 - $105,242
-360 Reduced 6.7%
5,012 $1.39 Million
Q4 2022

Feb 02, 2023

SELL
$252.44 - $306.72 $328,676 - $399,349
-1,302 Reduced 19.51%
5,372 $1.49 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $414,689 - $571,819
2,130 Added 46.88%
6,674 $1.78 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $35,632 - $42,373
-190 Reduced 4.01%
4,544 $927,000
Q1 2022

May 09, 2022

SELL
$193.77 - $244.14 $1.52 Million - $1.92 Million
-7,848 Reduced 62.37%
4,734 $997,000
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $14,778 - $18,992
-66 Reduced 0.52%
12,582 $3.02 Million
Q3 2021

Nov 09, 2021

BUY
$282.99 - $369.05 $28,299 - $36,905
100 Added 0.8%
12,648 $3.58 Million
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $75,628 - $121,095
-292 Reduced 2.27%
12,548 $4.34 Million
Q1 2021

May 12, 2021

SELL
$242.95 - $284.63 $124,876 - $146,299
-514 Reduced 3.85%
12,840 $3.59 Million
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $314,225 - $472,987
-1,330 Reduced 9.06%
13,354 $3.27 Million
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $896,775 - $1.04 Million
3,387 Added 29.98%
14,684 $4.17 Million
Q2 2020

Aug 04, 2020

SELL
$258.66 - $342.55 $3.19 Million - $4.22 Million
-12,327 Reduced 52.18%
11,297 $3.02 Million
Q1 2020

May 04, 2020

SELL
$268.85 - $341.04 $1.47 Million - $1.86 Million
-5,455 Reduced 18.76%
23,624 $7.47 Million
Q4 2019

Feb 10, 2020

BUY
$220.06 - $304.07 $4.37 Million - $6.04 Million
19,879 Added 216.08%
29,079 $8.63 Million
Q3 2019

Oct 22, 2019

BUY
$217.44 - $243.88 $2 Million - $2.24 Million
9,200 New
9,200 $2.14 Million
Q2 2019

Aug 15, 2019

SELL
$219.29 - $241.72 $33,551 - $36,983
-153 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $4.97 Million - $7.77 Million
-22,915 Reduced 99.34%
153 $36,000
Q4 2018

Feb 06, 2019

SELL
$278.5 - $352.75 $7.7 Million - $9.75 Million
-27,632 Reduced 54.5%
23,068 $6.94 Million
Q3 2018

Oct 16, 2018

BUY
$293.51 - $383.83 $5.96 Million - $7.79 Million
20,300 Added 66.78%
50,700 $17.9 Million
Q2 2018

Jul 17, 2018

SELL
$257.52 - $306.91 $461,475 - $549,982
-1,792 Reduced 5.57%
30,400 $8.82 Million
Q1 2018

Apr 26, 2018

SELL
$260.13 - $367.91 $683,621 - $966,867
-2,628 Reduced 7.55%
32,192 $8.82 Million
Q4 2017

Feb 05, 2018

SELL
$307.64 - $344.58 $864,776 - $968,614
-2,811 Reduced 7.47%
34,820 $11.1 Million
Q3 2017

Oct 30, 2017

BUY
$281.15 - $329.69 $10.6 Million - $12.4 Million
37,631
37,631 $11.8 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.